Fake $497 million purchase in Colombia https://www.halconesypalomas.com/2021/08/17/canadiense-leviathan-completo-compra-por-497-millones-de-colombiana-de-cannabis-natural-origins/
False report even in the combian press
Canadian Leviathan completed $497 million purchase of Colombian cannabis company Natural Origins Leviathan Natural Products announced that it has completed the acquisition of all issued and outstanding shares of Natural Origins SAS, a Colombian company licensed to grow, process and export psychoactive. and non-psychoactive cannabis.
The Colombian subsidiary, LCG Holdings Inc (LGC) had agreed with Natural Origins to pay in total consideration COP 497,818,080 at the exchange rate of COP 3,842 per US$1 (US$129,539) paid to all shareholders of the Origin Shares in the following payment schedule:
COP 70,442,000 of the Consideration Price was paid at the time of signing the Agreement; 100,000,000 were paid on January 25, 2021 plus 1,820,379 COP of default interest; On April 9, 2021, 209,157,500 COP were paid for the purchase of 50% of the Origins Shares plus 9,486,701 of delinquent interest; and 96,911,500 on August 6, 2021, to purchase the remaining 50% of Origins shares. As a result of this operation, Leviathan appointed Roy Ostrom III as chief executive officer of LCG Holdings, LLC. Graduated in Education from The London School of Economics and Political Science (LSE), worked at New York Bear Stearns Investment Bank and co-founded and led the operations of Touchstone Gold in Segovia, Antioquia, and is currently managing director of Swiss SPC.
Each Origins shareholder received a portion of the Consideration Price in proportion to the number of Origins shares each owned. No company securities were issued under the terms of the Agreement.
Leviathan Natural Products Inc. recently announced results for the third quarter ending May 31, 2021. For the third quarter, the company announced total revenue of CAD$165,966. The net loss was CAD 924,891 compared to CAD 526,164 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
During the nine months, the total income was 325,386 Canadian dollars. The net loss was CAD 2.78 million compared to CAD 1.82 million a year earlier. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago.
Martin J. Doane, CEO of Leviathan Natural Products and CEO of Leviathan USA, is a law graduate with 27 years of complex dispute resolution experience coupled with two decades of capital markets activity. and corporate governance.
LCG is currently in the process of upgrading the facility on its 22-acre property in Carmen de Viboral, Colombia. LCG intends to cultivate specialized strains of cannabis and hemp with high concentrations of CBD, CBG and CBN, for the extraction and manufacture of cannabinoid products under the Licenses, including bulk and branded products. Additionally, LCG plans to cultivate medicinal mushrooms for nutraceutical uses and for medical R&D and plans to sell them to licensed biotech and other research groups around the world. The expected completion date for the first phase of the Colombian installation is in the second calendar of 2022.
"Leveraging Colombia's strong export regime, LCG intends to sell its products in key markets in South America, Europe and Asia, leveraging Leviathan's global networks and LCG's executive team," he explained in a press release.
"The acquisition of Natural Origins represents a significant milestone for the company," said Martin J. Doane, CEO of Leviathan. “There is a strict regulatory framework and process for licenses in Colombia, which means they are highly coveted and not easy to obtain. Our well-equipped and well-positioned facilities coupled with ownership of a government-authorized license that enables the global export of psychoactive and non-psychoactive products to represent exceptional value and strong revenue-generating potential.”
Leviathan primarily focuses on non-psychoactive hemp-derived products for the health and wellness market. Leviathan plans to execute a series of buy-build transactions that span all vertical markets in Canada and internationally.
Leviathan's portfolio currently comprises Jekyll + Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis/hemp industry; Leviathan US, Inc., which began manufacturing cannabidiol products in August 2020 from its facilities in Carthage, Tennessee; LCG Holdings Inc., a cannabis and hemp cultivation and processing facility in Carmen de Viboral, Colombia, expected to be operational in the second quarter of 2022; and Woodstock Biomed Inc., which owns a 30-acre property with greenhouse infrastructure in Pelham, Ontario.
The Woodstock property operates under a lease agreement with Medical Saints Ltd., a licensed producer of industrial hemp regulated by Health Canada. The agreement allows for significant research and development ("R&D") in the industrial hemp sector.